Physician profile
Lorena Gutierrez
NPI 1477000743
$6,499.17
in general payments reported to CMS, 2019-2025
39 companies · $775 in 2025
The $775 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,764 · 2022: $1,549 · 2023: $1,359 · 2024: $1,052 · 2025: $775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,185.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $582.41 | 2021-2025 | |
| Amgen INC. | $565.18 | 2021-2025 | Otezla, Repatha, Evenity |
| Glaxosmithkline, LLC. | $526.72 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $499.33 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $475.23 | 2021-2025 | Ozempic, Rybelsus, Tresiba |
| Boehringer Ingelheim Pharmaceuticals, INC. | $376.89 | 2021-2023 | Tradjenta, Jardiance |
| Abbvie INC. | $370.80 | 2021-2025 | |
| Lilly USA, LLC | $339.31 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $306.99 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $298.54 | 2021-2025 | |
| Abbott Laboratories | $296.91 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Exact Sciences Corporation | $207.91 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $205.53 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $159.70 | 2021-2024 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Amarin Pharma, INC. | $149.45 | 2021-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorena Gutierrez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.